(Q34222234)

31 July 2017

title

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. (English)

1 reference

31 July 2017

1 reference

12

Ulrike Blume-Peytavi

1 reference

31 July 2017

Anja Blumeyer

1

1 reference

31 July 2017

Antonella Tosti

2

1 reference

31 July 2017

Andrew Messenger

3

1 reference

31 July 2017

Pascal Reygagne

4

1 reference

31 July 2017

Veronique Del Marmol

5

1 reference

31 July 2017

Phyllis I Spuls

6

1 reference

31 July 2017

Myrto Trakatelli

7

1 reference

31 July 2017

Andreas Finner

8

1 reference

31 July 2017

Franklin Kiesewetter

9

1 reference

31 July 2017

Ralph Trüeb

10

1 reference

31 July 2017

Berthold Rzany

11

1 reference

31 July 2017

European Dermatology Forum (EDF)

13

1 reference

31 July 2017

publication date

1 October 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

9 Suppl 6

1 reference

31 July 2017

page(s)

S1-57

1 reference

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Susceptibility variants for male-pattern baldness on chromosome 20p11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Male-pattern baldness susceptibility locus at 20p11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Topical minoxidil therapy for androgenetic alopecia. A 30-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Minoxidil vs finasteride in the treatment of men with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Comparative efficacy of various treatment regimens for androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Finasteride in the treatment of men with frontal male pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Effects of finasteride (1 mg) on hair transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Topical estrogen therapy for androgenetic alopecia in menopausal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Dissecting microscope versus magnifying loupes with transillumination in the preparation of follicular unit grafts. A bilateral controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The role of platelet plasma growth factors in male pattern baldness surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The diagnosis and treatment of iron deficiency and its potential relationship to hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The role of hair follicles in the percutaneous absorption of caffeine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Electrotrichogenesis: further evidence of efficacy and safety on extended use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

Androgenetic alopecia in adolescents: a report of 43 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0379.2011.07802.X

10.1111/J.1610-0379.2011.07802.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference